B Cells May Play A Pathological Role In Hepatic Inflammation In Chronic Liver Diseases

Rui Huang,Hongyan Wu,Yong Liu,Yali Xiong,Juan Xia,Zhiyun Pan,Guiyang Wang,Zhenhua Sun,Xiaomin Yan,Jun Chen,Zhaoping Zhang,Chao Wu
2016-01-01
Abstract:B cells have been proven to promote liver inflammation and fibrotic responses in animal models. However, whether B cells may play a pathological role in patients with chronic liver diseases (CLD) remains unclear. B cells were determined by immunohistochemistry in the liver tissues of 93 CLD patients with different etiologies and 23 normal liver tissue specimens in the present study. We found that the density of CD20 positive B cells was significantly increased in the liver tissues of CLD patients with different etiologies compared to normal liver tissues. CLD patients with higher inflammatory grades had significantly more CD20 positive B cells infiltration in their livers compared to those with lower grades. However, intrahepatic CD20 positive B cells were not positively associated with liver fibrosis stages in these patients. Intrahepatic B cells were positively correlated with serum alanine aminotransferase (r=0.467, P<0.001), aspartate aminotransferase (r=0.310, P=0.003), alkaline phosphatase (r=0.316, P=0.002) and gamma-glutamyl transferase levels (r=0.247, P=0.019) in CLD patients. The results of the present study suggest that B cells may play a pathological role in hepatic inflammation in CLD patients caused by different etiologies. A clear understanding of the phenotype and functional roles of intrahepatic B cell in CLD should be further elucidated.
What problem does this paper attempt to address?